Patel Sanj K sold KNSA
November 2, 2026 · Form 4 insider transaction
Patel Sanj K sold 26,781 shares of Kiniksa Pharmaceuticals International, plc at $93.06 per share, a transaction worth $2.49M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
26,781
Price
$93.06
Total value
$2.49M
InsiderPatel Sanj K
RoleOfficer, Director
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateNovember 2, 2026
Filing dateNovember 3, 2026
Shares owned after869,981
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging from $92.695 to $93.51. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.